nandrolone decanoate- nandrolone decanoate injection
watson laboratories, inc. - nandrolone decanoate (unii: h45187t098) (nandrolone - unii:6pg9vr430d) - injection - nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. surgically induced anephric patients have been reported to be less responsive. - male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. - carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. - pregnancy, because of masculinization of the fetus. pregnancy, because of masculinization of the fetus. - nephrosis or the nephrotic phase of nephritis. nephrosis or the nephrotic phase of nephritis. nandrolone decanoate injection is classified as a schedule iii controlled substance under the anabolic steroids control act of
nandrolone decanoate - nandrolone decanoate injection, solution
american regent, inc. - nandrolone decanoate (unii: h45187t098) (nandrolone - unii:6pg9vr430d) - nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. surgically induced anephric patients have been reported to be less responsive. - male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. - carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. - pregnancy, because of masculinization of the fetus. - nephrosis or the nephrotic phase of nephritis. nandrolone decanoate injection is classified as a schedule iii controlled substance under the anabolic steroids control act of 1990.
nandrolone phenylpropionate
rwr veterinary products pty ltd - nandrolone phenylpropionate - unknown - nandrolone phenylpropionate steroid-anabolic active 0.0 - active constituent
nandrolone decanoate
rwr veterinary products pty ltd - nandrolone decanoate - unknown - nandrolone decanoate steroid-anabolic active 0.0 - active constituent
nandrolone laurate
intervet australia pty limited - nandrolone laurate - unknown - nandrolone laurate steroid-anabolic active 0.0 - active constituent
retabolil 50mg/ml solution for injection, oily
gedeon richter ojsc - nandrolone (nandrolone decanoate) - solution for injection, oily - 50mg/ml
myodine 25 mg/ml inj. sol. s.c./i.m. vial
dechra regulatory b.v. - nandrolone laurate 25 mg/ml - eq. nandrolone 15 mg/ml - solution for injection - 25 mg/ml - nandrolone laurate 25 mg/ml - nandrolone - dog; cat
myodine 25 mg/ml inj. sol. s.c./i.m. vial
dechra regulatory b.v. - nandrolone laurate 25 mg/ml - eq. nandrolone 15 mg/ml - solution for injection - 25 mg/ml - nandrolone laurate 25 mg/ml - nandrolone - cat; dog
laurabolin 25 mg/ml anabolic steroid for intramuscular or subcutaneous injection
intervet australia pty limited - nandrolone laurate - parenteral liquid/solution/suspension - nandrolone laurate steroid-anabolic active 25.0 mg/ml - endocrine system - cat | dog | horse | horse foal | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | g - anabolic steroid | abortion threat | androgenic properties | bone repair | catabolic complications | convalescence | erythropoietic activity | geriatric therapy | improve appetite | male sexual characterisitics | muscle development | non-virilising anabolic | pathophysiological process | protein and mineral anabolic | skeletal conditions | tissue breakdown | tissue repair | virilising anabolic
nandrosol 25 mg/ml solution for injection for dogs and cats
cp-pharma handelsgesellschaft mbh - nandrolone laurate - solution for injection - 25 milligram(s)/millilitre - nandrolone